Александра Синицына (Ночной линейный редактор)
Фото: Петр Ковалев / ТАСС
，推荐阅读pg电子官网获取更多信息
The drug, called orforglipron and manufactured by Eli Lilly, is prescribed for type 2 diabetes and targets the same GLP-1 receptors as oral semaglutide. Like semaglutide, it lowers blood sugar levels, slows digestion and suppresses appetite. Unlike semaglutide tablets, it does not need to be taken on an empty stomach.，更多细节参见谷歌
Click to expand.，详情可参考超级权重